ong-term efficacy and safety of istradefylline for the treatment of advanced Parkinson's disease
Not Applicable
- Conditions
- Parkinson&#39s disease
- Registration Number
- JPRN-UMIN000021899
- Lead Sponsor
- Abe Neurology Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with moderate or severe liver disorder or taking medications that strongly inhibit CYP3A4 2.Patients who are nursing or pregnant or might be pregnant 3.Patients in whom efficacy data were not collected at 6 and 12 months after oral treatment with istradefylline
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method